Fundamental Analysis (FA)
Framework: DCF Benchmarked
Join Palmy To Bypass The Blur →
For SCI
Valuation Weak
28%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Weak
33%
Per Share Metrics Weak
33%
Fin. Health n.A.
Fundamental Analysis (FA)
Benchmarked
1 Financial Health
Metric Q3 Q4 Δ in %
Current Ratio -6.97 0.62 0.67
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA 3.68 14.45 13.94
Naive Interpretation member
2 Per Share
Metric Q3 Q4 Δ in %
Book Value 3.95 10.87 10.46
Cash 3.54 1.43 -1.38
Capex 14.54 -0.55 -0.64
Free Cash Flow -22.98 0.96 1.25
Revenue -0.26 7.15 7.17
Naive Interpretation member
3 Profitability
Metric Q3 Q4 Δ in %
Gross Margin -3.69 0.26 0.27
Operating Margin -2.85 0.22 0.23
ROA -7.06 < 0.005 < 0.005
ROE -8.07 0.08 0.09
ROIC -2.51 0.03 0.03
Naive Interpretation member
4 Valuation
The "Valuation Entry" for the Focus of SCI is permitted for members.
5 Growth
The "Growth Entry" for the Focus of SCI is permitted for members.
6 Leverage & Liquidity
The "Leverage & Liquidity Entry" for the Focus of SCI is permitted for members.